Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Sirtuin activators and inhibitors.
Villalba JM, Alcaín FJ.
Biofactors. 2012 Sep-Oct;38(5):349-59. doi: 10.1002/biof.1032. Epub 2012 Jun 25. Review.
Related citations
Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment.
Fujitaka K, Otani H, Jo F, Jo H, Nomura E, Iwasaki M, Nishikawa M, Iwasaka T, Das DK.
Nutr Res. 2011 Nov;31(11):842-7. doi: 10.1016/j.nutres.2011.09.028.
Modulation of microRNA 20b with resveratrol and longevinex is linked with their potent anti-angiogenic action in the ischaemic myocardium and synergestic effects of resveratrol and γ-tocotrienol.
Mukhopadhyay P, Das S, Ahsan MK, Otani H, Das DK.
J Cell Mol Med. 2012 Oct;16(10):2504-17. doi: 10.1111/j.1582-4934.2011.01480.x.
Hormetic response of resveratrol against cardioprotection.
Juhasz B, Mukherjee S, Das DK.
Exp Clin Cardiol. 2010 Winter;15(4):e134-8.
Restoration of altered microRNA expression in the ischemic heart with resveratrol.
Mukhopadhyay P, Mukherjee S, Ahsan K, Bagchi A, Pacher P, Das DK.
PLoS One. 2010 Dec 23;5(12):e15705. doi: 10.1371/journal.pone.0015705.
Effects of Longevinex (modified resveratrol) on cardioprotection and its mechanisms of action.
Mukherjee S, Ray D, Lekli I, Bak I, Tosaki A, Das DK.
Can J Physiol Pharmacol. 2010 Nov;88(11):1017-25. doi: 10.1139/y10-082.
Reduction of blood cholesterol and ischemic injury in the hypercholesteromic rabbits with modified resveratrol, longevinex. [corrected]
Juhasz B, Das DK, Kertesz A, Juhasz A, Gesztelyi R, Varga B.
Mol Cell Biochem. 2011 Feb;348(1-2):199-203. doi: 10.1007/s11010-010-0615-2. Epub 2010 Nov 4. Erratum in: Mol Cell Biochem. 2011 Feb;348(1-2):205. Juhaz, Bela [corrected to Juhasz, Bela].
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on